InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,430.40
(
0.14%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.59
(
-0.24%
)
Bitcoin
65,275.26
(
0.21%
)
Post# of 13959
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Letterpenny

Send PM Follow Ignore
Followers 7
Posts 6049
Boards Moderated 0
Alias Born 06/27/2018

Letterpenny

Member Level

Re: None

Friday, 06/07/2019 8:32:39 AM

Friday, June 07, 2019 8:32:39 AM

Post# of 13959
Just to make double sure no little minds are scurrying: Immune has ownership of all patents etc for all indications and all improvements including these ones. So screw the rights. And screw the sub license. Bert has ownership of all improvements and has patents for everything. Let’s move on to the next lie. Have a good day.

Immune Pharmaceuticals and Hadasit File a Joint Patent on the Oral Use of Anti-Eotaxin Monoclonal Antibodies, Including Bertilimumab, for the Treatment of GI and Liver Diseases
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up